Cargando…

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes

Aims/Introduction: The effectiveness of incretin‐based therapies in Asian type 2 diabetes requires investigation of the secretion and metabolism of glucose‐dependent insulinotropic polypepide (GIP) and glucagon‐like peptide 1 (GLP‐1). Plasma extractions have been suggested to reduce variability in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yabe, Daisuke, Watanabe, Koin, Sugawara, Kenji, Kuwata, Hitoshi, Kitamoto, Yuka, Sugizaki, Kazu, Fujiwara, Shuichi, Hishizawa, Masahiro, Hyo, Takanori, Kuwabara, Kyoko, Yokota, Kayo, Iwasaki, Masahiro, Kitatani, Naomi, Kurose, Takeshi, Inagaki, Nobuya, Seino, Yutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014935/ https://www.ncbi.nlm.nih.gov/pubmed/24843548 http://dx.doi.org/10.1111/j.2040-1124.2011.00141.x

Ejemplares similares

Retrospective analysis of safety and efficacy of insulin‐to‐liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β‐cell function
por: Usui, Ryota, et al.
Publicado: (2013)

Predicting efficacy of dipeptidyl peptidase‐4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels
por: Iwasaki, Masahiro, et al.
Publicado: (2012)

The journey to understanding incretin systems: Theory, practice and more theory
por: Yabe, Daisuke, et al.
Publicado: (2019)

Meal sequence and glucose excursion, gastric emptying and incretin secretion in type 2 diabetes: a randomised, controlled crossover, exploratory trial
por: Kuwata, Hitoshi, et al.
Publicado: (2015)

Incretin‐based drugs for type 2 diabetes: Focus on East Asian perspectives
por: Seino, Yutaka, et al.
Publicado: (2016)

Stimulatory effect of imeglimin on incretin secretion
por: Yingyue, Quan, et al.
Publicado: (2023)

GIP and GLP‐1, the two incretin hormones: Similarities and differences
por: Seino, Yutaka, et al.
Publicado: (2010)

Cardiovascular safety trials of incretin‐based drugs: What do they mean?
por: Yabe, Daisuke, et al.
Publicado: (2016)

Little enhancement of meal‐induced glucagon‐like peptide 1 secretion in Japanese: Comparison of type 2 diabetes patients and healthy controls
por: Yabe, Daisuke, et al.
Publicado: (2010)

Glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1: Incretin actions beyond the pancreas
por: Seino, Yutaka, et al.
Publicado: (2013)

Incretin concept revised: The origin of the insulinotropic function of glucagon‐like peptide‐1 – the gut, the islets or both?
por: Yabe, Daisuke, et al.
Publicado: (2017)

Glutamate Acts as a Key Signal Linking Glucose Metabolism to Incretin/cAMP Action to Amplify Insulin Secretion
por: Gheni, Ghupurjan, et al.
Publicado: (2014)

Incretin Concepts
por: Bloomgarden, Zachary T.
Publicado: (2010)

Inflammation and incretins
por: Hatwal, Amitabh
Publicado: (2012)

GIP: An Inconsequential Incretin or Not?
por: Pratley, Richard E.
Publicado: (2010)

Pleiotropic effects of incretins
por: Gupta, Vishal
Publicado: (2012)

Incretin-based therapies
por: Stonehouse, Anthony H, et al.
Publicado: (2012)

An analysis of intestinal morphology and incretin-producing cells using tissue optical clearing and 3-D imaging
por: Hatoko, Tomonobu, et al.
Publicado: (2022)

Establishment of new clonal pancreatic β‐cell lines (MIN6‐K) useful for study of incretin/cyclic adenosine monophosphate signaling
por: Iwasaki, Masahiro, et al.
Publicado: (2010)

Effect of Glycemia on Plasma Incretins and the Incretin Effect During Oral Glucose Tolerance Test
por: Salehi, Marzieh, et al.
Publicado: (2012)

Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion
por: Joo, Erina, et al.
Publicado: (2015)

Understanding the Cardiovascular Effects of Incretin
por: Yoon, Ji Sung, et al.
Publicado: (2011)

Incretin hormones as immunomodulators of atherosclerosis
por: Alonso, Nuria, et al.
Publicado: (2012)

Therapy in the Early Stage: Incretins
por: Cernea, Simona, et al.
Publicado: (2011)

Incretin hormones and the satiation signal
por: Holst, J J
Publicado: (2013)

Novel extrapancreatic effects of incretin
por: Yamada, Yuichiro, et al.
Publicado: (2016)

Incretins in patients with rheumatoid arthritis
por: Tejera-Segura, Beatriz, et al.
Publicado: (2017)

The Origin and Understanding of the Incretin Concept
por: Rehfeld, Jens F.
Publicado: (2018)

Molecular Pharmacology of the Incretin Receptors
por: Al-Sabah, Suleiman
Publicado: (2016)

Effects of glucose and meal ingestion on incretin secretion in Japanese subjects with normal glucose tolerance
por: Yamane, Shunsuke, et al.
Publicado: (2011)

The Incretin Effect in Female Mice With Double Deletion of GLP-1 and GIP Receptors
por: Ahrén, Bo, et al.
Publicado: (2019)

β‐Cell glutamate signaling: Its role in incretin‐induced insulin secretion
por: Yokoi, Norihide, et al.
Publicado: (2016)

Bone: Incretin Hormones Perceiver or Receiver?
por: Dicembrini, Ilaria, et al.
Publicado: (2012)

Pancreatitis Associated With Incretin-Based Therapies
por: Iyer, Shridhar N., et al.
Publicado: (2013)

Do incretins improve endothelial function?
por: Oyama, Jun-ichi, et al.
Publicado: (2014)

Incretin action on bone: An added benefit?
por: Ma, Ronald C W, et al.
Publicado: (2015)

Molecular mechanisms of incretin hormone secretion()
por: Ezcurra, Marina, et al.
Publicado: (2013)

Incretins in the Therapy of Diabetic Kidney Disease
por: Przezak, Agnieszka, et al.
Publicado: (2021)

Bariatric Surgery: It’s Not Just Incretins!
por: Ferraz-Bannitz, Rafael, et al.
Publicado: (2021)

Editorial: Incretin agonists in the treatment of obesity
por: Sun, Xiaodong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b17tcen27uld94hnu188p8fp0s